Please enable javascript in your browser to view this page correctly
You need to upgrade your Flash Player| Recommendation | Level of Evidence | Net Benefit | Grade of Recommendation |
|---|---|---|---|
| Calcium Channel blockers Acute responders to vasoreactivity testing, defined as fall in mean PAP ≥ 10mmHG to ≤ 40mmHg with increased or unchanged cardiac output and absence of right heart failure may be treated with oral CCBs, with careful reassessment 1. Idiopathic PAH 2. Secondary PAH from underlying conditions |
low expert opinion |
substantial intermediate |
B E/B |
| Sildenafil Patients who are not candidates or in whom CCB therapy has failed can initiate long term therapy for the following functional class: 1. II or III 2. IV |
Good Low |
Substantial Intermediate |
A C |
For the complete table please download the pdf file at the top.